Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Cash & Equivalents (2016 - 2025)

Hypha Labs' Cash & Equivalents history spans 15 years, with the latest figure at $147192.0 for Q2 2025.

  • For Q2 2025, Cash & Equivalents fell 71.08% year-over-year to $147192.0; the TTM value through Jun 2025 reached $147192.0, down 71.08%, while the annual FY2024 figure was $91166.0, 66.36% down from the prior year.
  • Cash & Equivalents reached $147192.0 in Q2 2025 per FUNI's latest filing, up from $21093.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.1 million in Q1 2024 to a low of $21093.0 in Q1 2025.
  • Average Cash & Equivalents over 5 years is $221218.2, with a median of $131530.0 recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 817.77% in 2024, then tumbled 98.02% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $90305.0 in 2021, then soared by 72.56% to $155832.0 in 2022, then surged by 97.81% to $308252.0 in 2023, then crashed by 88.13% to $36583.0 in 2024, then soared by 302.35% to $147192.0 in 2025.
  • Per Business Quant, the three most recent readings for FUNI's Cash & Equivalents are $147192.0 (Q2 2025), $21093.0 (Q1 2025), and $36583.0 (Q4 2024).